Monday, December 1, 2008 - 8:42PM EST

Review Articles

11. Breast cancer during pregnancy: epidemiology, surgical treatment, and staging.

Author
Gentilini O;
Institution
Breast Surgery, European Institute of Oncology, Milan, Italy.
Journal
Recent Results Cancer Res. 2008;178:39-44.

12. Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer.

Author
O'Brien ME;
Institution
Royal Marsden Hospital, NHS Trust, Sutton, Surrey, UK. maryo'brien@rmh.nhs.uk
Journal
Anticancer Drugs. 2008 Jan;19(1):1-7.
Abstract URL
Click here to view abstract

13. A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.

Author
Pruthi S; Boughey JC; Brandt KR; Degnim AC; Dy GK; Goetz MP; Perez EA; Reynolds CA; Schomberg PJ; Ingle JN;
Institution
Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. pruthi.sandhya@mayo.edu
Journal
Mayo Clin Proc. 2007 Sep;82(9):1131-40.
Abstract URL
Click here to view abstract

14. Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety.

Author
Lazaridis G; Pentheroudakis G; Pavlidis N;
Institution
Department of Medical Oncology, Ioannina University Hospital, Niarxou Avenue, 45500 Ioannina, Greece.
Journal
Crit Rev Oncol Hematol. 2008 Apr;66(1):31-41. Epub 2007 Sep 4.
Abstract URL
Click here to view abstract

15. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review.

Author
Lemieux J; Maunsell E; Provencher L;
Institution
Unite de recherche en sante des populations, Centre hospitalier affilie universitaire de Quebec, Quebec, Que, Canada. julie.lemieux@uresp.ulaval.ca
Journal
Psychooncology. 2008 Apr;17(4):317-28.
Abstract URL
Click here to view abstract

16. A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis.

Author
Pruthi S; Brandt KR; Degnim AC; Goetz MP; Perez EA; Reynolds CA; Schomberg PJ; Dy GK; Ingle JN;
Institution
Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. pruthi.sandhya@mayo.edu
Journal
Mayo Clin Proc. 2007 Aug;82(8):999-1012.
Abstract URL
Click here to view abstract

17. Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006.

Author
Ng R; Pond GR; Tang PA; MacIntosh PW; Siu LL; Chen EX; Ng R; Pond GR; Tang PA; MacIntosh PW; Siu LL; Chen EX;
Institution
Department of Medical Oncology and Hematology, Princess Margaret Hospital, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Journal
Ann Oncol. 2008 Mar;19(3):481-6. Epub 2007 Nov 20.
Abstract URL
Click here to view abstract

18. Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.

Author
Dodwell D; Williamson D;
Institution
Cookridge Hospital, Hospital Lane, Leeds LS16 6QB, UK. David.Dodwell@leedsth.nhs.uk
Journal
Cancer Treat Rev. 2008 Apr;34(2):137-44. Epub 2007 Nov 14.
Abstract URL
Click here to view abstract

19. Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

Author
Dean-Colomb W; Esteva FJ;
Institution
The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. festeva@mdanderson.org
Journal
Semin Oncol. 2008 Apr;35(2 Suppl 2):S31-8; quiz S40.
Abstract URL
Click here to view abstract

20. Clinical studies with epothilones for the treatment of metastatic breast cancer.

Author
Vahdat LT;
Institution
Division of Hematology/Oncology, Weill Medical College of Cornell University, New York, NY 20021. ltv2001@med.cornell.edu
Journal
Semin Oncol. 2008 Apr;35(2 Suppl 2):S22-30; quiz S40.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6